ZYN001 / LTS Lohmann Therapy Systems, Paragon Biosciences - LARVOL DELTA

An Update of Current Cannabis-Based Pharmaceuticals in Pain Medicine. (PubMed, Pain Ther) - "...The cannabidiol oral solution Epidiolex®, which is available in the USA, is indicated for management of refractory epilepsy but may offer therapeutic relief to chronic pain conditions as well. Current investigative drugs, such as those developed by Cara Therapeutics and Zynerba Pharmaceuticals, are synthetic cannabinoids which show promise to specifically target neuropsychiatric conditions and chronic pain symptoms such as neuropathy and allodynia. The objective of this review is to provide clinicians with an update of currently available and promising developmental cannabis pharmaceutical derivatives which may stand to greatly benefit patients with otherwise difficult-to-treat chronic conditions."

Journal • Review